US Stock MarketDetailed Quotes

Abbott Laboratories (ABT)

Watchlist
  • 91.130
  • -1.350-1.46%
Close Apr 24 16:00 ET
  • 91.490
  • +0.360+0.40%
Post 19:59 ET
158.72BMarket Cap25.53P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Abbott Laboratories (ABT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
7.78%11.16B
5.67%44.33B
4.42%11.46B
6.90%11.37B
7.37%11.14B
3.95%10.36B
4.59%41.95B
7.16%10.97B
4.85%10.64B
4.00%10.38B
Operating revenue
7.78%11.16B
5.67%44.33B
4.42%11.46B
6.90%11.37B
7.37%11.14B
3.95%10.36B
4.59%41.95B
7.16%10.97B
4.85%10.64B
4.00%10.38B
Cost of revenue
9.44%4.89B
3.28%19.32B
-0.40%4.92B
8.02%5.08B
5.45%4.85B
0.11%4.47B
4.07%18.71B
8.47%4.94B
2.02%4.7B
2.68%4.6B
Gross profit
6.52%6.27B
7.59%25.01B
8.37%6.54B
6.01%6.29B
8.90%6.29B
7.07%5.89B
5.01%23.24B
6.10%6.03B
7.20%5.94B
5.08%5.77B
Operating expense
17.44%4.93B
3.27%16.96B
4.00%4.29B
3.90%4.24B
3.19%4.24B
1.99%4.2B
4.87%16.42B
5.53%4.12B
4.81%4.08B
3.85%4.11B
Selling and administrative expenses
22.18%3.74B
5.43%12.33B
7.64%3.13B
5.39%3.05B
5.28%3.09B
3.45%3.06B
6.83%11.7B
6.72%2.91B
6.32%2.9B
7.15%2.94B
Research and development costs
7.12%767M
3.45%2.94B
-1.87%735M
7.43%766M
3.87%725M
4.68%716M
3.76%2.84B
7.00%749M
6.10%713M
-2.38%698M
Depreciation amortization depletion
0.48%422M
-10.44%1.68B
-9.25%422M
-10.64%420M
-10.83%420M
-11.02%420M
-4.48%1.88B
-3.33%465M
-5.24%470M
-5.42%471M
-Depreciation and amortization
0.48%422M
-10.44%1.68B
-9.25%422M
-10.64%420M
-10.83%420M
-11.02%420M
-4.48%1.88B
-3.33%465M
-5.24%470M
-5.42%471M
Operating profit
-20.56%1.35B
17.99%8.05B
17.79%2.25B
10.65%2.06B
22.95%2.05B
22.15%1.69B
5.36%6.83B
7.36%1.91B
12.87%1.86B
8.24%1.67B
Net non-operating interest income expense
-38.78%-68M
13.95%-185M
6.67%-42M
13.73%-44M
13.79%-50M
19.67%-49M
14.68%-215M
35.71%-45M
26.09%-51M
4.92%-58M
Non-operating interest income
----
-10.47%308M
-14.29%78M
-15.38%77M
-13.41%71M
2.50%82M
-10.65%344M
2.25%91M
-6.19%91M
-16.33%82M
Non-operating interest expense
-48.09%68M
-11.81%493M
-11.76%120M
-14.79%121M
-13.57%121M
-7.09%131M
-12.24%559M
-14.47%136M
-14.46%142M
-11.95%140M
Other net income (expense)
28.36%172M
48.39%598M
-9.15%149M
26.52%167M
3,800.00%148M
20.72%134M
-7.99%403M
92.94%164M
41.94%132M
-102.58%-4M
Gain on sale of security
85.71%13M
85.19%50M
50.00%15M
54.55%17M
83.33%11M
--7M
165.85%27M
141.67%10M
10.00%11M
128.57%6M
Other non- operating income (expenses)
25.20%159M
45.74%548M
-12.99%134M
23.97%150M
1,470.00%137M
14.41%127M
-21.50%376M
41.28%154M
45.78%121M
-105.68%-10M
Income before tax
-18.50%1.45B
20.72%8.47B
16.16%2.36B
12.37%2.18B
33.79%2.15B
23.82%1.78B
5.24%7.01B
13.09%2.03B
16.10%1.94B
-1.77%1.61B
Income tax
-17.88%372M
130.40%1.94B
108.08%582M
82.31%536M
21.64%371M
114.69%453M
-778.96%-6.39B
-3,681.59%-7.2B
25.11%294M
16.86%305M
Net income
-18.72%1.08B
-51.32%6.52B
-80.76%1.78B
-0.12%1.64B
36.64%1.78B
8.16%1.33B
134.18%13.4B
478.98%9.23B
14.62%1.65B
-5.31%1.3B
Net income continuous Operations
-18.72%1.08B
-51.32%6.52B
-80.76%1.78B
-0.12%1.64B
36.64%1.78B
8.16%1.33B
134.18%13.4B
478.98%9.23B
14.62%1.65B
-5.31%1.3B
Minority interest income
Net income attributable to the parent company
-18.72%1.08B
-51.32%6.52B
-80.76%1.78B
-0.12%1.64B
36.64%1.78B
8.16%1.33B
134.18%13.4B
478.98%9.23B
14.62%1.65B
-5.31%1.3B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-18.72%1.08B
-51.32%6.52B
-80.76%1.78B
-0.12%1.64B
36.64%1.78B
8.16%1.33B
134.18%13.4B
478.98%9.23B
14.62%1.65B
-5.31%1.3B
Basic earnings per share
-18.45%0.6198
-51.37%3.73
-80.81%1.0227
0.00%0.94
37.84%1.02
8.57%0.76
133.84%7.67
479.78%5.3295
14.63%0.94
-6.33%0.74
Diluted earnings per share
-19.74%0.61
-51.31%3.72
-80.83%1.01
0.00%0.94
36.49%1.01
8.57%0.76
134.36%7.64
479.12%5.27
14.63%0.94
-5.13%0.74
Dividend per share
6.78%0.63
7.27%2.36
7.27%0.59
7.27%0.59
7.27%0.59
7.27%0.59
7.84%2.2
7.84%0.55
7.84%0.55
7.84%0.55
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 7.78%11.16B5.67%44.33B4.42%11.46B6.90%11.37B7.37%11.14B3.95%10.36B4.59%41.95B7.16%10.97B4.85%10.64B4.00%10.38B
Operating revenue 7.78%11.16B5.67%44.33B4.42%11.46B6.90%11.37B7.37%11.14B3.95%10.36B4.59%41.95B7.16%10.97B4.85%10.64B4.00%10.38B
Cost of revenue 9.44%4.89B3.28%19.32B-0.40%4.92B8.02%5.08B5.45%4.85B0.11%4.47B4.07%18.71B8.47%4.94B2.02%4.7B2.68%4.6B
Gross profit 6.52%6.27B7.59%25.01B8.37%6.54B6.01%6.29B8.90%6.29B7.07%5.89B5.01%23.24B6.10%6.03B7.20%5.94B5.08%5.77B
Operating expense 17.44%4.93B3.27%16.96B4.00%4.29B3.90%4.24B3.19%4.24B1.99%4.2B4.87%16.42B5.53%4.12B4.81%4.08B3.85%4.11B
Selling and administrative expenses 22.18%3.74B5.43%12.33B7.64%3.13B5.39%3.05B5.28%3.09B3.45%3.06B6.83%11.7B6.72%2.91B6.32%2.9B7.15%2.94B
Research and development costs 7.12%767M3.45%2.94B-1.87%735M7.43%766M3.87%725M4.68%716M3.76%2.84B7.00%749M6.10%713M-2.38%698M
Depreciation amortization depletion 0.48%422M-10.44%1.68B-9.25%422M-10.64%420M-10.83%420M-11.02%420M-4.48%1.88B-3.33%465M-5.24%470M-5.42%471M
-Depreciation and amortization 0.48%422M-10.44%1.68B-9.25%422M-10.64%420M-10.83%420M-11.02%420M-4.48%1.88B-3.33%465M-5.24%470M-5.42%471M
Operating profit -20.56%1.35B17.99%8.05B17.79%2.25B10.65%2.06B22.95%2.05B22.15%1.69B5.36%6.83B7.36%1.91B12.87%1.86B8.24%1.67B
Net non-operating interest income expense -38.78%-68M13.95%-185M6.67%-42M13.73%-44M13.79%-50M19.67%-49M14.68%-215M35.71%-45M26.09%-51M4.92%-58M
Non-operating interest income -----10.47%308M-14.29%78M-15.38%77M-13.41%71M2.50%82M-10.65%344M2.25%91M-6.19%91M-16.33%82M
Non-operating interest expense -48.09%68M-11.81%493M-11.76%120M-14.79%121M-13.57%121M-7.09%131M-12.24%559M-14.47%136M-14.46%142M-11.95%140M
Other net income (expense) 28.36%172M48.39%598M-9.15%149M26.52%167M3,800.00%148M20.72%134M-7.99%403M92.94%164M41.94%132M-102.58%-4M
Gain on sale of security 85.71%13M85.19%50M50.00%15M54.55%17M83.33%11M--7M165.85%27M141.67%10M10.00%11M128.57%6M
Other non- operating income (expenses) 25.20%159M45.74%548M-12.99%134M23.97%150M1,470.00%137M14.41%127M-21.50%376M41.28%154M45.78%121M-105.68%-10M
Income before tax -18.50%1.45B20.72%8.47B16.16%2.36B12.37%2.18B33.79%2.15B23.82%1.78B5.24%7.01B13.09%2.03B16.10%1.94B-1.77%1.61B
Income tax -17.88%372M130.40%1.94B108.08%582M82.31%536M21.64%371M114.69%453M-778.96%-6.39B-3,681.59%-7.2B25.11%294M16.86%305M
Net income -18.72%1.08B-51.32%6.52B-80.76%1.78B-0.12%1.64B36.64%1.78B8.16%1.33B134.18%13.4B478.98%9.23B14.62%1.65B-5.31%1.3B
Net income continuous Operations -18.72%1.08B-51.32%6.52B-80.76%1.78B-0.12%1.64B36.64%1.78B8.16%1.33B134.18%13.4B478.98%9.23B14.62%1.65B-5.31%1.3B
Minority interest income
Net income attributable to the parent company -18.72%1.08B-51.32%6.52B-80.76%1.78B-0.12%1.64B36.64%1.78B8.16%1.33B134.18%13.4B478.98%9.23B14.62%1.65B-5.31%1.3B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -18.72%1.08B-51.32%6.52B-80.76%1.78B-0.12%1.64B36.64%1.78B8.16%1.33B134.18%13.4B478.98%9.23B14.62%1.65B-5.31%1.3B
Basic earnings per share -18.45%0.6198-51.37%3.73-80.81%1.02270.00%0.9437.84%1.028.57%0.76133.84%7.67479.78%5.329514.63%0.94-6.33%0.74
Diluted earnings per share -19.74%0.61-51.31%3.72-80.83%1.010.00%0.9436.49%1.018.57%0.76134.36%7.64479.12%5.2714.63%0.94-5.13%0.74
Dividend per share 6.78%0.637.27%2.367.27%0.597.27%0.597.27%0.597.27%0.597.84%2.27.84%0.557.84%0.557.84%0.55
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -